STOCK TITAN

CareMax, Inc. - $CMAX STOCK NEWS

Welcome to our dedicated page for CareMax news (Ticker: $CMAX), a resource for investors and traders seeking the latest updates and insights on CareMax stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CareMax's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CareMax's position in the market.

Rhea-AI Summary
CareMax, Inc. (CMAX) met its 2023 guidance for Medicare Advantage membership and total revenue, with year-end 2023 Medicare Advantage membership of 111,500, up 19% year-over-year, and full-year 2023 total revenue of $751.1 million, also up 19% year-over-year. The company is exploring strategic options to maximize the value of certain assets and generate further liquidity.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23.47%
Tags
-
Rhea-AI Summary
CareMax, Inc. announces a 1-for-30 reverse stock split of its Class A common stock, expected to be effective on January 31, 2024. The split is intended to regain compliance with the Nasdaq's minimum bid price requirement and will reduce the number of issued and outstanding shares from approximately 112.4 million to 3.7 million. The Class A Common Stock will continue to trade on the Nasdaq under the symbol 'CMAX' and is expected to begin trading on a split-adjusted basis on February 1, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3218.41%
Tags
-
Rhea-AI Summary
CareMax, Inc. (NASDAQ: CMAX; CMAXW) announced a 171% year-over-year increase in third-quarter Medicare Advantage Membership to 107,000 and a 28% year-over-year increase in total revenue to $201.8 million. The company is reaffirming its full-year 2023 revenue guidance, updating its Medicare Advantage Membership and Adjusted EBITDA guidance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.08%
Tags
Rhea-AI Summary
CareMax, Inc. will release its financial results for the third quarter 2023 on November 9, 2023. A conference call will be held to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.22%
Tags
-
Rhea-AI Summary
CareMax CEO and CFO to participate in fireside chat at Morgan Stanley conference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.38%
Tags
conferences
-
Rhea-AI Summary
CareMax, Inc. announces Q2 results with Medicare Advantage membership up 177% YoY and total revenue up 30% YoY. The company is raising its full year 2023 revenue guidance and reaffirming its adjusted EBITDA guidance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
Rhea-AI Summary
CareMax, Inc. will release its financial results for the second quarter 2023 on August 9, 2023, and host a conference call to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.55%
Tags
-
Rhea-AI Summary
CareMax, Inc. will participate in a fireside chat at the Jefferies Healthcare Conference on June 7, 2023. CEO Carlos de Solo and CFO Kevin Wirges will discuss the company's value-based care to seniors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.54%
Tags
conferences
-
Rhea-AI Summary
CareMax, Inc. (NASDAQ: CMAX; CMAXW) announced its financial results for Q1 2023. The company reported a Medicare Advantage membership of 95,500, up 181% YoY, and a total revenue of $173.0 million, up 26% YoY. The net loss for the quarter was $82.1 million, compared to a net loss of $16.8 million in Q1 2022. Adjusted EBITDA was negative $0.1 million, compared to $3.8 million in Q1 2022. CareMax reaffirmed its full year 2023 guidance, projecting a year-end Medicare Advantage membership of 110,000 to 120,000 and a total revenue of $700 million to $750 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.24%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.84%
Tags
CareMax, Inc.

Nasdaq:CMAX

CMAX Rankings

CMAX Stock Data

12.63M
1.98M
24.24%
59.36%
6.09%
Dental Laboratories
Manufacturing
Link
United States of America
MIAMI